CNMD
CONMED Corporation
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Best Electromedical Stocks 2026 →
CONMED (CNMD) Stock: Buy, Sell, or Hold?
$51.21
-0.73 (-1.41%)
▼
5d:
+8.43%
30d:
+12.9%
90d:
+3.5%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (37%)
Quality Score
37/100
Position
EXTENDED
30-Day Fair Range
$44.75 – $50.01
Position: EXTENDED
Forward P/E & Valuation
10.8x
STRETCHED
vs 8.7x historical avg
Wall Street Target
$46.83
-8.5% vs target
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$43.50 / $54.80
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: CNMD shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When CNMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$50.15
Based on 4.0% avg growth
INTRINSIC VALUE TODAY
$31.14
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CNMD is currently trading at $51.21, which is considered extended relative to its 30-day fair value range of $44.75 to $50.01. From a valuation perspective, the stock is trading at a premium (Forward PE: 10.8) compared to its historical average (8.7). At these levels, the market is pricing in 7.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CNMD is in a uptrend. Immediate support is located at $43.50, while resistance sits at $54.80.
Market Sentiment: CNMD scores 13/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CNMD is in a uptrend. Immediate support is located at $43.50, while resistance sits at $54.80.
Market Sentiment: CNMD scores 13/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$44.75 -
$50.01
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
36.5%
Trading Range & Key Levels
30-Day Trading Range
$44.75 -
$50.01
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$3.36
(6.6%)
Support Level
$43.50
Resistance Level
$54.80
Current Trend
Uptrend
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding CNMD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (13/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($46.83)
- NEUTRAL: PE elevated vs history but 7.3% growth expectation is conservative given 633% recent growth
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
10.78
Wall Street Target
$46.83
(-8.5%)
Revenue Growth (YoY)
-0.7%
Earnings Growth (YoY)
633.3%
Profit Margin
5.4%
Valuation Premium vs History
+7.3% premium
PE vs Historical
10.8 vs 8.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+7.3%
(market-implied from PE analysis)
1-Year Target
$54.95
(+7%)
2-Year Target
$58.96
(+15%)
3-Year Target
$63.26
(+24%)
3-Yr Target (if PE normalizes)
(PE: 11→9)
PE COMPRESSION
$51.04
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 3.9%)
$105.65
(+106%)
Base:
(SPY PE: 10.8, Growth: 3.9%)
$57.36
(+12%)
Bear:
(PE: 8.7, Growth: 3.9%)
$46.28
(-10%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 21.55 | Current EPS (TTM): $2.41
Bull Case
$112.59
(+120%)
Analyst growth 97.1%, PE expands to 23.7
Base Case
$102.35
(+100%)
Market implied 97.1%, PE stable at 21.6
Bear Case
$35.32
(-31%)
Severe decline -20.0%, PE contracts to 18.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share CNMD Analysis
Share this live CNMD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CNMD)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 29, 2026
Daily AI digest
AI Retail Discussion Summary:
Investor $CNMD reports Q3 2026 earnings of $1.04 per share, exceeding estimates by 4.0%. Sales were in line with estimates at $335.6 million, with full-year revenue guidance maintained.
Key Retail Themes:
Earnings report
Revenue and EPS beat
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 10, 2026 8:58 PM ET
Data refreshes hourly during market hours. Next update: 9:58 PM
Data refreshes hourly during market hours. Next update: 9:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 47 HOLD |
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 53 HOLD |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 35 SELL |
|
PODD
Insulet Corporation |
BUY
26 analysts |
$178 | 43 HOLD |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 49 HOLD |
Advanced CNMD Option Strategies
Professional options setups generated by AI based on today's CNMD price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CNMD Research Pages
